High-dose interleukin-2 can produce a high rate of response and durable remissions in appropriately selected patients with metastatic renal cancer

Alaaeldin Shablak, Kanwal Sikand, Jonathan H. Shanks, Fiona Thistlethwaite, Andrea Spencer-Shaw, Robert E. Hawkins

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'High-dose interleukin-2 can produce a high rate of response and durable remissions in appropriately selected patients with metastatic renal cancer'. Together they form a unique fingerprint.

    Medicine and Dentistry